QUANTITATION OF IMMUNOCYTOCHEMICAL ESTROGEN AND PROGESTERONE-RECEPTOR CONTENT IN FINE-NEEDLE ASPIRATES OF BREAST-CARCINOMA USING THE SAMBA-4000 IMAGE-ANALYSIS SYSTEM

被引:0
作者
AUGER, M
KATZ, RL
JOHNSTON, DA
SNEIGE, N
ORDONEZ, NG
FRITSCHE, H
机构
[1] UNIV TEXAS,M D ANDERSON CANC CTR,DEPT ANAT PATHOL,CYTOPATHOL SECT,HOUSTON,TX 77030
[2] UNIV TEXAS,M D ANDERSON CANC CTR,DEPT ANAT PATHOL,SURG PATHOL SECT,HOUSTON,TX 77030
[3] UNIV TEXAS,M D ANDERSON CANC CTR,DEPT BIOMATH,HOUSTON,TX 77030
[4] UNIV TEXAS,M D ANDERSON CANC CTR,DEPT LAB MED,HOUSTON,TX 77030
来源
ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY | 1993年 / 15卷 / 04期
关键词
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Evaluation of estrogen receptors (ER) and progesterone receptors (PR) in breast carcinoma using ER and PR immunocytochemical assays (ER-ICA and PR-ICA) has traditionally been semiquantitative at best. We investigated the use of the SAMBA 4000 image analysis system for quantitation of immunocytochemical ER content in 23 cases and PR content in 20 cases of breast carcinoma after obtaining cytology specimens by fine needle aspiration (FNA). We compared the quantitative assessment obtained by image analysis, the quick score (QS), to the biochemical assay as well as to the ER-ICA and PR-ICA semiquantitative visual histochemical score (H-score). Using Pearson's linear correlation coefficient, we demonstrated that for both ER and PR, the QS obtained by the ''area'' or ''nuclear'' programs correlated significantly with the H-scores. However, while the QS obtained on the area program for both ER and PR correlated significantly with the biochemical assay, the QS obtained on the nuclear program did not. The discrepancy might reflect the smaller number of cells evaluated with the nuclear program as compared to the area one. These results show that the SAMBA 4000 system provides an objective means of quantitating ER and PR content by immunocytochemical methods.
引用
收藏
页码:274 / 280
页数:7
相关论文
共 22 条
[1]   ESTROGEN-RECEPTOR STATUS - IMPORTANT VARIABLE IN PREDICTING RESPONSE TO ENDOCRINE THERAPY IN METASTATIC BREAST-CANCER [J].
ALLEGRA, JC ;
LIPPMAN, ME ;
THOMPSON, EB ;
SIMON, R ;
BARLOCK, A ;
GREEN, L ;
HUFF, KK ;
DO, HMT ;
AITKEN, SC ;
WARREN, R .
EUROPEAN JOURNAL OF CANCER, 1980, 16 (03) :323-331
[2]   THE EVALUATION OF ESTROGEN-RECEPTOR IN PRIMARY BREAST-CARCINOMA BY COMPUTER-ASSISTED IMAGE-ANALYSIS [J].
BACUS, S ;
FLOWERS, JL ;
PRESS, MF ;
BACUS, JW ;
MCCARTY, KS .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1988, 90 (03) :233-239
[3]  
CHARPIN C, 1988, AM J PATHOL, V132, P199
[4]  
CHARPIN C, 1989, CANCER, V63, P863, DOI 10.1002/1097-0142(19890301)63:5<863::AID-CNCR2820630512>3.0.CO
[5]  
2-P
[6]  
CHARPIN C, 1986, CANCER RES, V46, P4271
[7]   PROGESTERONE RECEPTORS AS A PROGNOSTIC FACTOR IN STAGE-II BREAST-CANCER [J].
CLARK, GM ;
MCGUIRE, WL ;
HUBAY, CA ;
PEARSON, OH ;
MARSHALL, JS .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (22) :1343-1347
[8]   IMAGE CYTOMETRY OF ESTROGEN-RECEPTORS IN BREAST CARCINOMAS [J].
COHEN, O ;
BRUGAL, G ;
SEIGNEURIN, D ;
DEMONGEOT, J .
CYTOMETRY, 1988, 9 (06) :579-587
[9]   IMMUNOHISTOCHEMICAL PROGESTERONE-RECEPTOR ASSAY - MEASUREMENT BY IMAGE-ANALYSIS [J].
ELBADAWY, N ;
COHEN, C ;
DEROSE, PB ;
CHECK, IJ ;
SGOUTAS, D .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1991, 96 (06) :704-710
[10]   USE OF MONOCLONAL ANTIESTROGEN RECEPTOR ANTIBODY TO EVALUATE ESTROGEN-RECEPTOR CONTENT IN FINE NEEDLE ASPIRATION BREAST BIOPSIES [J].
FLOWERS, JL ;
BURTON, GV ;
COX, EB ;
MCCARTY, KS ;
DENT, GA ;
GEISINGER, KR ;
MCCARTY, KS .
ANNALS OF SURGERY, 1986, 203 (03) :250-254